The novel STAT3 inhibitor WZ-2-033 causes regression of human triple-negative breast cancer and gastric cancer xenografts
Yan Zhong(Zhejiang Chinese Medical University), Xiaolei Zhang(Jiangsu Province Hospital)
Cited by 35
Related Papers
Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
|Proceedings of the National Academy of Sciences|2012|347
ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m6A-dependent manner
|Annals of Translational Medicine|2020|105
Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer
|Gynecologic Oncology|2014|58
Effects of probiotics, probiotic DNA and the CpG oligodeoxynucleotides on ovalbumin-sensitized Brown-Norway rats via TLR9/NF-κB pathway
|FEMS Immunology & Medical Microbiology|2012|34
<p>Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo</p>
|OncoTargets and Therapy|2020|9